Phibro Animal Health (PAHC) Operating Expenses (2012 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Operating Expenses of $81.2 million in Q1 2026, down 1.66% quarter-over-quarter from $82.5 million in Q4 2025, and up 13.2% on a YoY basis from $71.7 million in Q1 2025.
Phibro Animal Health (PAHC) Operating Expenses (2012 - 2026) Analysis & Trends
Phibro Animal Health's Operating Expenses history runs 15 years deep, the most recent figure standing at $81.2 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 13.2% year-over-year to $81.2 million; the TTM figure through Mar 2026 stood at $299.7 million (up 1.65% YoY), while the FY2025 annual figure was $293.3 million, up 12.72% from the prior year.
- Operating Expenses was $81.2 million for Q1 2026 at Phibro Animal Health, down from $82.5 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $85.2 million in Q4 2024 to a low of $52.4 million in Q1 2022.
- Historically, Operating Expenses has averaged $65.9 million across 5 years, with a median of $67.2 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses slipped 4.75% in 2023, then surged 35.34% in 2024.
- A 5-year view of Operating Expenses shows it stood at $61.5 million in 2022, then climbed by 2.23% to $62.9 million in 2023, then soared by 35.34% to $85.2 million in 2024, then dropped by 3.09% to $82.5 million in 2025, then slipped by 1.66% to $81.2 million in 2026.
- The last three Operating Expenses figures came in at $81.2 million (Q1 2026), $82.5 million (Q4 2025), and $68.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 526.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 788.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 455.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 19.40 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 621.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 478.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 441.19 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 475.11 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 96.91 Mn |
| 10 | Phibro Animal Health | 1.32 Bn | 1.24 Bn | 125.68 Mn | 81.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.15 Mn |
| Dec 31, 2025 | 82.52 Mn |
| Sep 30, 2025 | 68.78 Mn |
| Jun 30, 2025 | 67.21 Mn |
| Mar 31, 2025 | 71.69 Mn |
| Dec 31, 2024 | 85.15 Mn |
| Sep 30, 2024 | 69.22 Mn |
| Jun 30, 2024 | 68.73 Mn |
| Mar 31, 2024 | 59.68 Mn |
| Dec 31, 2023 | 62.92 Mn |
| Sep 30, 2023 | 68.45 Mn |
| Jun 30, 2023 | 52.90 Mn |
| Mar 31, 2023 | 56.99 Mn |
| Dec 31, 2022 | 61.54 Mn |
| Sep 30, 2022 | 54.96 Mn |
| Jun 30, 2022 | 55.54 Mn |
| Mar 31, 2022 | 52.43 Mn |
| Dec 31, 2021 | 48.38 Mn |
| Sep 30, 2021 | 50.07 Mn |
| Jun 30, 2021 | 50.67 Mn |